Tweetovi

Blokirali ste korisnika/cu @mtmdphd

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @mtmdphd

  1. Prikvačeni tweet
    20. sij

    1/ [Thread] -> Timeline of Vaccination & Abx in Multiple Myeloma [Updated Jan 20, 2020]

    Prikaži ovu nit
    Poništi
  2. proslijedio/la je Tweet

    Special shout out & 🙏 to Director of Fellowship Education Dr GGM & Co-Director for inviting me to speak at their successful & innovative Leukemia Fellows Lecture Series.Honored to present 101 to such a highly motivated & engaged group !

    , , i još njih 5
    Poništi
  3. proslijedio/la je Tweet
    prije 11 sati

    Excited that fabulous favorite clin health mentor, Psychoonc guruness & friend is on Twitter! Please share with us yr brillance & pearls of wisdom-incl pearls-for inspiration!;)

    Poništi
  4. proslijedio/la je Tweet

    Our Board of Directors are on the Hill today sharing the importance of , “The Access to Genetic Counselor Services Act,” and gathering support from Congress! Learn more about the bill and how you can support:

    , , i još njih 2
    Poništi
  5. Seven Decades of Chemotherapy : A Pan-Cancer Social Network Analysis [Nov 2, 2019] Li et al.   

    Poništi
  6. Knowledge Empowers Us [Nov 29, 2017]

    Poništi
  7. Myeloma-ologists -> Let me know if you are interested in being a Discussant for Twitter chat in future. cc:

    Poništi
  8. proslijedio/la je Tweet
    21. sij
    Poništi
  9. proslijedio/la je Tweet

    Another meeting means a new lineup of Featured Voices! Excited to follow everyone’s commentary from afar (☀️Orlando sounds way better than gloomy DC!).

    Poništi
  10. Poništi
  11. proslijedio/la je Tweet

    Very nice paper from Dr Bastidas Torres et al (The Netherlands 🇳🇱 + Italy 🇮🇹 collaboration) Whole‐genome analysis uncovers recurrent inactivation&aberrant cell adhesion in {Genes, Chromosomes and Cancer 2020 Wiley Online Library}

    Poništi
  12. ...and et alia !

    Prikaži ovu nit
    Poništi
  13. (Multiple Myeloma Social Media) healthcare social media hashtag - via

    Poništi
  14. proslijedio/la je Tweet

    Read the conclusion. The trial used Len continuous like maintenance. Our conclusion was 2 years in the paper to match the Spanish group

    Poništi
  15. proslijedio/la je Tweet
    Odgovor korisniku/ci

    Patients need to understand what group of SMM will benefit most. What criteria is being used? The SMM gets confused with the evolving definitions. SMM patients seeing community Oncs need to be their own advocates with facts in hand.

    Poništi
  16. Thank you all -- especially chat

    Prikaži ovu nit
    Poništi
  17. T5 Questions and future

    Poništi
  18. 3 minutes

    Poništi
  19. T4 "Other" ->Moving From Cancer Burden to Cancer Genomics for Smoldering Myeloma [SMM]: A Review [Dec 12, 2019] et al.

    Poništi
  20. You can do a deep dive into the multiple Figures & Tables (incl addendum) -> Ph3 RCT Len vs Obs in SMM [10/25/19] et al. E3A06 T2

    Poništi
  21. proslijedio/la je Tweet

    T4 ASCENT: KRD-6 cycles induction; 6 cycles consolidation; 12 cycles of maintenance NCT03289299

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·